[Geographic variability in prescribing antibiotics in the pediatric population of Castille and León during 2001-2005]

M E Vázquez1, E Pastor, M R Bachiller

  • 1marvazfer@hotmail.com

Insights

Antibiotic use in children varied significantly across Spain

Area of Science:

  • Pediatric Pharmacology
  • Public Health
  • Infectious Disease Epidemiology

Background:

  • Antibiotic consumption is a key factor in antimicrobial resistance.
  • Understanding pediatric antibiotic prescribing patterns is crucial for public health initiatives.
  • Variability in antibiotic use can indicate differences in clinical practice and resource allocation.

Purpose of the Study:

  • To assess antibiotic consumption differences in pediatric populations across eleven Primary Health Care centers in Castilla Leon (2001-2005).
  • To analyze potential causes for observed variations in antibiotic prescribing.
  • To evaluate both quantitative and qualitative aspects of antibiotic use in this region.

Main Methods:

  • Analysis of non-hospital antibiotic consumption data from the Health Service of Castilla Leon.
  • Data categorized using the Anatomic Therapeutic Chemical Classification System (ATC).
  • Consumption expressed as defined daily doses per 1000 inhabitants per day (DID).

Main Results:

  • Statistically significant differences in antibiotic use were found, with rates varying by 8.3 DID between Leon (highest) and Soria (lowest).
  • Prescribing patterns and temporal fluctuations in antibiotic use showed considerable variation, notably in Segovia.
  • Penicillin with beta-lactamase inhibitors varied nearly threefold between Burgos and Segovia; Segovia demonstrated good management, while Soria showed low consumption but misuse.

Conclusions:

  • Significant quantitative and qualitative variability in pediatric antibiotic use exists among primary health care centers in Castilla Leon.
  • Further research is needed on age groups, socioeconomic factors, and indications to fully understand antibiotic use determinants in children.
  • Optimizing antibiotic prescribing requires addressing both consumption levels and adherence to recommended guidelines.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...